Literature DB >> 16397396

CARD15 single nucleotide polymorphisms 8, 12 and 13 are not increased in ethnic Danes with sarcoidosis.

Nils Milman1, Ole Haagen Nielsen, Thomas Vauvert F Hviid, Kirsten Fenger.   

Abstract

BACKGROUND: Mutations of the caspase-activating recruitment domain 15 (CARD15) gene on chromosome 16 are associated with chronic inflammatory granulomatous bowel disease (Crohn's disease). Sarcoidosis is a systemic granulomatous disease with unknown etiology, which shares histological features with Crohn's disease.
OBJECTIVES: To evaluate whether ethnic Danes with sarcoidosis have an increased frequency of CARD15 mutations compared to healthy control subjects.
METHODS: Genotyping for CARD15 mutations R702W, G908R, and L1007fsinsC, also designated single nucleotide polymorphism (SNP) SNP8, SNP12 and SNP13, respectively, were performed by capillary electrophoresis single-strand confirmation polymorphism in 53 patients with histologically verified sarcoidosis and in 103 healthy controls.
RESULTS: The frequencies of CARD15 mutations in sarcoidosis patients were: SNP8, 4/106 chromosomes (3.8%); SNP12, 2/106 chromosomes (1.9%); SNP13, 2/106 chromosomes (1.9%); SNP8+SNP12+SNP13, 8/106 chromosomes (7.6%). All 8 patients were heterozygous. The frequencies in controls were: SNP8, 9/206 chromosomes (4.4%); SNP12, 2/206 chromosomes (1.0%); SNP13, 4/206 chromosomes (1.9%); SNP8+SNP12+SNP13, 15/206 chromosomes (7.3%). All controls were heterozygous. The differences were not statistically significant (p>0.05). Furthermore, the course of disease was not significantly different in the 8 patients with CARD15 mutations and the 45 patients without mutations.
CONCLUSION: The frequency of CARD15 mutations is not increased in ethnic Danish patients with sarcoidosis, and heterozygosity for such mutations apparently has no influence on the course of disease. Copyright (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16397396     DOI: 10.1159/000090638

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  10 in total

Review 1.  The Nodosome: Nod1 and Nod2 control bacterial infections and inflammation.

Authors:  Ivan Tattoli; Leonardo H Travassos; Leticia A Carneiro; Joao G Magalhaes; Stephen E Girardin
Journal:  Semin Immunopathol       Date:  2007-08-10       Impact factor: 9.623

Review 2.  NOD2/CARD15 gene polymorphisms and sarcoidosis susceptibility: review and meta-analysis.

Authors:  Xuping Chen; Zhenxing Zhou; Yi Zhang; Xiaoliang Cheng; Xiaowen Guo; Xiaodong Yang
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

3.  Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis.

Authors:  M Veltkamp; P A H M Wijnen; C H M van Moorsel; G T Rijkers; H J T Ruven; M Heron; O Bekers; A M E Claessen; M Drent; J M M van den Bosch; J C Grutters
Journal:  Clin Exp Immunol       Date:  2007-06-12       Impact factor: 4.330

Review 4.  The puzzling clinical spectrum and course of juvenile sarcoidosis.

Authors:  Andrew Fretzayas; Maria Moustaki; Olga Vougiouka
Journal:  World J Pediatr       Date:  2011-05-15       Impact factor: 2.764

Review 5.  NOD2: ethnic and geographic differences.

Authors:  Juleen Cavanaugh
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

Review 6.  Etiologies of Sarcoidosis.

Authors:  Edward S Chen; David R Moller
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

7.  Toll-like receptor 2 (TLR2) gene polymorphisms are not associated with sarcoidosis in the Japanese population.

Authors:  Mayuki Sato; Tatsukata Kawagoe; Akira Meguro; Masao Ota; Yoshihiko Katsuyama; Mami Ishihara; Kenichi Namba; Nobuyoshi Kitaichi; Shin-ichiro Morimoto; Toshikatsu Kaburaki; Yasutaka Ando; Shinobu Takenaka; Shigeaki Ohno; Hidetoshi Inoko; Nobuhisa Mizuki
Journal:  Mol Vis       Date:  2011-03-15       Impact factor: 2.367

Review 8.  The spectrum of autoinflammatory diseases: recent bench to bedside observations.

Authors:  John G Ryan; Raphaela Goldbach-Mansky
Journal:  Curr Opin Rheumatol       Date:  2008-01       Impact factor: 5.006

9.  Evidence for impaired CARD15 signalling in Crohn's disease without disease linked variants.

Authors:  Jakob Benedict Seidelin; Oliver Jay Broom; Jørgen Olsen; Ole Haagen Nielsen
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

10.  G908R NOD2 variant in a family with sarcoidosis.

Authors:  Valérie Besnard; Alain Calender; Diane Bouvry; Yves Pacheco; Catherine Chapelon-Abric; Florence Jeny; Hilario Nunes; Carole Planès; Dominique Valeyre
Journal:  Respir Res       Date:  2018-03-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.